THRD — Third Harmonic Bio Balance Sheet
0.000.00%
- $233.21m
- -$51.85m
- 34
- 38
- 26
- 24
Annual balance sheet for Third Harmonic Bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 8.28 | 128 | 289 | 269 | 285 |
Prepaid Expenses | |||||
Total Current Assets | 8.43 | 129 | 293 | 272 | 291 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | — | — | 4.36 | 3.93 | 3.17 |
Other Long Term Assets | |||||
Total Assets | 8.43 | 129 | 299 | 278 | 295 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 2.21 | 5.69 | 5.65 | 5.42 | 7.11 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 8.09 | 5.69 | 9.61 | 8.63 | 9.46 |
Redeemable Preferred Stock | |||||
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 0.342 | 123 | 289 | 269 | 285 |
Total Liabilities & Shareholders' Equity | 8.43 | 129 | 299 | 278 | 295 |
Total Common Shares Outstanding |